Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437680 · ClinicalTrials.gov registry record
Retrospective Chart Review Study of Patients Treated With Votiva Device
A clinical trial, sponsored by InMode MD.
- Completed
- Registry status
- 600
- Enrollment target
NCT04437680: Completed study, sponsored by InMode MD.
NCT04437680 is a clinical trial that has completed, run by InMode MD. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04437680 has completed, sponsored by InMode MD.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
retrospective data collection is to gain insight into patients satisfaction post Votiva treatments for the complex of vulvovaginal symptoms.
Primary Outcome
• Participant satisfaction post treatment. Number of patients who are satisfied with post treatment results \[ Time Frame: Baseline to 4 weeks post-treatment/s\]
Interventions
- DEVICE Votiva device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2020-06-05 |
| Est. Completion | 2020-12-30 |
What the finished NCT04437680 record still lists
NCT04437680 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Votiva device is the first listed.
NCT04437680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04437680 about?
NCT04437680 is a clinical study titled "Retrospective Chart Review Study of Patients Treated With Votiva Device". retrospective data collection is to gain insight into patients satisfaction post Votiva treatments for the complex of vulvovaginal symptoms.
What is the current status of trial NCT04437680?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2020-06-05. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT04437680?
The interventions under investigation include: Votiva device (DEVICE).
Who is sponsoring clinical trial NCT04437680?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI